Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
Australian School of Petroleum
Business School
Elder Conservatorium of Music
Law School
School of Agriculture, Food and Wine
School of Animal and Veterinary Sciences
School of Architecture and Built Environment
School of Chemical Engineering
School of Chemistry and Physics
School of Civil, Environmental and Mining Engineering
School of Computer Science
School of Dentistry
School of Earth and Environmental Sciences
School of Economics
School of Education
School of Electrical and Electronic Engineering
School of History and Politics
School of Humanities
School of Mathematical Sciences
School of Mechanical Engineering
School of Medical Sciences
School of Medicine
School of Molecular and Biomedical Science
School of Nursing
School of Paediatrics & Reproductive Health
School of Population Health & Clinical Practice
School of Psychology
School of Social Sciences
School of Translational Health Science
Research Outputs
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 11-20 of 74 (Search time: 0.004 seconds).
previous
1
2
3
4
5
...
8
next
Item hits:
Preview
Issue Date
Title
Author(s)
2013
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CML
Branford, S.
;
Yeung, D.
;
Ross, D.
;
Prime, J.
;
Field, C.
;
Altamura, H.
;
Yeoman, A.
;
Georgievski, J.
;
Jamison, B.
;
Phillis, S.
;
Sullivan, B.
;
Briggs, N.
;
Hertzberg, M.
;
Seymour, J.
;
Reynolds, J.
;
Hughes, T.
2013
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
Ross, D.
;
Branford, S.
;
Seymour, J.
;
Schwarer, A.
;
Arthur, C.
;
Yeung, D.
;
Dang, P.
;
Goyne, J.
;
Slader, C.
;
Filshie, R.
;
Mills, A.
;
Vaz de Melo, J.
;
White, D.
;
Grigg, A.
;
Hughes, T.
2013
Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase
Hochhaus, A.
;
Saglio, G.
;
Larson, R.
;
Kim, D.
;
Etienne, G.
;
Rosti, G.
;
De Souza, C.
;
Kurokawa, M.
;
Kalaycio, M.
;
Hoenekopp, A.
;
Fan, X.
;
Shou, Y.
;
Kantarjian, H.
;
Hughes, T.
2013
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Baccarani, M.
;
Deininger, M.
;
Rosti, G.
;
Hochhaus, A.
;
Soverini, S.
;
Apperley, J.
;
Cervantes, F.
;
Clark, R.
;
Cortes, J.
;
Guilhot, F.
;
Hansen-Hjorth, H.
;
Hughes, T.
;
Kantarjian, H.
;
Kim, D.
;
Larson, R.
;
Lipton, J.
;
Mahon, F.
;
Martinelli, G.
;
Mayer, J.
;
Muller, M.
;
et al.
2013
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy
Angelini, S.
;
Soverini, S.
;
Ravegnini, G.
;
Barnett, M.
;
Turrini, E.
;
Thornquist, M.
;
Pane, F.
;
Hughes, T.
;
White, D.
;
Radich, J.
;
Kim, D.
;
Saglio, G.
;
Cilloni, D.
;
Iacobucci, I.
;
Perini, G.
;
Woodman, R.
;
Cantelli-Forti, G.
;
Baccarani, M.
;
Hrelia, P.
;
Martinelli, G.
2009
Predicting the response of CML patients to tyrosine kinase inhibitor therapy
White, D.
;
Hughes, T.
2006
Role of allogeneic stem cell transplantation for adult chronic myeloid leukemia in the imatinib era
Grigg, A.
;
Hughes, T.
2000
A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia
Branford, S.
;
Rudzi, Z.
;
Hughes, T.
2006
Autologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: Back to the bench
Hui, C.
;
Hughes, T.
2009
Imatinib mesylate causes growth plate closure in vivo
Vandyke, K.
;
Dewar, A.
;
Menicanin, D.
;
To, L.
;
Hughes, T.
;
Zannettino, A.
;
Fitter, S.
Discover
Author
28
White, D.
27
Branford, S.
17
Hochhaus, A.
11
Radich, J.
11
Saunders, V.
10
Zannettino, A.
9
Cortes, J.
8
Grigg, A.
8
Kantarjian, H.
8
Saglio, G.
.
next >
Subject
55
Pyrimidines
48
Imatinib Mesylate
45
Benzamides
45
Piperazines
35
Antineoplastic Agents
34
Fusion Proteins, bcr-abl
33
Protein Kinase Inhibitors
22
Treatment Outcome
21
Adult
21
Male
.
next >
Date issued
1
2020 - 2022
38
2010 - 2019
35
2000 - 2009